To treat or not to treat is one of the most difficult dilemmas facing prostate cancer patients, especially elderly men with early prostate cancer or small cancer that is contained within the prostate.ObjectiveThe primary objective of this review is to analyse the treatment options for patients ...
The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is often treated with androgen deprivation therapy, which lowers testos...
DNPC is difficult to treat and frequently arises in patients previously treated with therapies that inhibitandrogen receptors(AR), known to spur prostatecancercells growth. Study findings were published in the July 18 online issue ofCancer Cell. Filippo Giancotti, M.D., Ph.D., professor of Canc...
Medical or surgical castration serves as the backbone of systemic therapy for advanced and metastatic prostate cancer, taking advantage of the importance of androgen signaling in this disease. Unfortunately, resistance to castration emerges almost universally. Despite the development and approval of new an...
Flutamide to Treat Prostate Cancer The U.S. Food and Drug Administration (FDA) approved the use of flutamide in the country on June 1996. It is commercialized under the brand name Eulexin to be used in the therapeutic areas of endocrinology, nephrology, oncology, family medicine, and urology....
Tommy Chong using pot to treat prostate cancerBy Lauren Moraski June 11, 2012 / 2:08 PM EDT / CBS News Tommy Chong speaks during the California Rural Legal Assistance Teguino Celebration Gala on Feb. 9, 2009, in Beverly Hills, Calif. Getty (CBS News) Comedian-actor Tommy Chong has ...
Alternative Antiandrogens to Treat Prostate Cancer Relapse After Initial Hormone Therapy We studied the efficiency of second or third line hormonal therapy for prostate cancer relapse after hormone therapy. The study included 70 patients with a... S Kojima,H Suzuki,K Akakura,... - 《Journal of ...
Molecular Profiles of Prostate Cancer: To Treat or Not to Treat. A major dilemma in the selection of treatment for men with prostate cancer is the difficulty in accurately characterizing the risk posed by the cancer. Thi... Itay,A,Sternberg,... - 《Annual Review of Medicine》 被引量: 7...
What is the best way not to treat prostate cancer? Selective treatment approaches for prostate cancer (PCa) are warranted given the highly varied nature of the disease and consequences of definitive therapy... MS Leapman,PR Carroll - 《Urologic Oncology Seminars & Original Investigations》 被引量...
Molecular Profiles of Prostate Cancer: To Treat or Not to Treat. A major dilemma in the selection of treatment for men with prostate cancer is the difficulty in accurately characterizing the risk posed by the cancer. Thi... Itay,A,Sternberg,... - 《Annual Review of Medicine》 被引量: 7...